Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,200 across all filing types
Latest filing 2022-08-18 AGM Information
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Annual General Meeting
AGM Information Classification · 95% confidence The document is a notice dated August 18, 2022, from Strides Pharma Science Limited regarding the 31st Annual General Meeting (AGM) scheduled for September 9, 2022. It includes the Notice of the AGM and the Annual Report for the fiscal year 2021-22. The text contains detailed information about the AGM agenda, including adoption of audited financial statements for the year ended March 31, 2022, re-appointment of directors, and auditors. It also includes explanatory statements and disclosures related to the AGM agenda items. The document is lengthy (15,000 characters) and contains substantive content related to the AGM and the Annual Report itself, not just an announcement or a brief notice. Therefore, it is not a mere report publication announcement or a regulatory filing. The presence of the Annual Report for FY 2021-22 and the AGM Notice together indicates this is a combined filing of AGM Information and Annual Report. Given the primary focus on the Annual Report and AGM Notice, the best classification is AGM Information (AGM-R) because the document is primarily the AGM Notice and related materials including the Annual Report for the fiscal year, which is typical for AGM filings in India. Confidence is high due to the detailed AGM notice and inclusion of the Annual Report for the fiscal year.
2022-08-18 English
Newspaper Advertisements
AGM Information Classification · 95% confidence The document is a short communication dated August 17, 2022, addressed to stock exchanges, referencing a newspaper advertisement about the 31st Annual General Meeting (AGM) of the company. It states that copies of the advertisement are enclosed and that the advertisement is also hosted on the company's website. The document is brief (1061 characters) and serves to inform the exchanges and public about the AGM advertisement publication. It does not contain the AGM materials themselves, nor detailed financial or management information. According to the 'Menu vs Meal' rule, this is an announcement related to the AGM, specifically about the advertisement for the AGM, not the AGM presentation or report itself. Therefore, the appropriate classification is AGM Information (AGM-R).
2022-08-17 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the successful completion of a US FDA inspection at the company's Singapore facility. It contains no financial statements, no detailed financial data, no regulatory filings, or voting results. It is a corporate announcement about operational compliance and inspection results. The document length is 3350 characters, which is relatively short and does not contain any report or detailed financial data. It is not an Annual Report, Interim Report, Earnings Release, or any other detailed financial or regulatory filing. It is also not a report publication announcement since it does not mention any report being published or attached. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other categories.
2022-08-08 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held on July 29, 2022, discussing the unaudited financial results for the quarter ended June 30, 2022. It includes management commentary on business performance, financial metrics, product launches, and Q&A with analysts. The presence of detailed financial discussion, forward-looking statements, and Q&A format is characteristic of an earnings call transcript. The document explicitly states it is the transcript of the earnings call and references the unaudited quarterly financial results. Therefore, the document fits the category of a Call Transcript (CT).
2022-08-04 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the USFDA approval of a pharmaceutical product by Strides Pharma Science Limited. It is dated August 3, 2022, and contains no financial statements or detailed financial analysis. The document is relatively short (4269 characters) and serves as a public announcement of a regulatory milestone rather than a financial report or detailed investor presentation. It does not fit into categories like Annual Report, Earnings Release, or Investor Presentation. It is clearly a press release, which is best classified under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit other specific categories.
2022-08-03 English
Loss of share certificate
Regulatory Filings
2022-08-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.